News
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: CS MEDICA Group Achieves Complete Registration of CANNASEN® CBD-Infused Medical Devices in Israel
CS MEDICA Group achieves complete registration of CANNASEN® CBD-infused medical devices in Israel, marking a significant milestone in expanding its global footprint and offering innovation in substance-based medical devices containing bioactive CBD -
COMMUNIQUÉ DE PRESSE
SINGULUS TECHNOLOGIES: Takeover offer for the bonds ISIN: DE000A2AA5H5 / WKN: A2AA5H does not originate from the company
SINGULUS TECHNOLOGIES AG announces that the public tender offer for the bonds ISIN: DE000A2AA5H5 does not originate from the company. The company plans to redeem the bonds on July 22, 2026 at EUR 105.00 per bond -
-
-
-
-
-